CAPR was identified as a high-potential biotechnology play ahead of a key FDA-related data release with favorable technical structure.
$CAPR
+400%
Capricor Therapeutics
+400%
Profit
in 7 days
Why did we enter?
What was happening?
Positive FDA-related data release triggered immediate market response.
What we did
This trade exemplifies the power of catalyst-driven biotech plays when proper risk management is applied. The technical setup showed accumulation patterns before the FDA announcement, signaling institutional interest. A 400% gain in 7 days demonstrates why biotech catalysts remain one of the most explosive trading opportunities.
Trade Details
Alert Date
11/01/2024
Entry Price
$2.50
Exit Price
$12.50
Profit Per Share
$10
Exit Date
11/08/2024
Time to Profit
7 days
Analyst
Peter
Security Manager
About Peter
Peter proves that your day job can become your biggest trading edge. Peter is a Mental ...